Latest News

A new national poll from Harvard School of Public Health (HSPH) researchers found that a majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so ..

Three leading scientific organizations specializing in infectious diseases prevention issued a letter to President Obama expressing their significant concern with current federal guidance concerning t ..

The distribution of swine flu vaccines to big name companies in New York has caused an uproar as people complain that children and health care workers should receive top priority. ..

The H1N1 (swine flu) virus is now the dominant flu strain worldwide, the WHO reported Thursday, with the virus accounting for up to 70 percent of the flu viruses sampled in some countries, the Associa ..

The NPHS influenza surveillance scheme, which records reports of diagnoses of flu from more than 300 GP practices across Wales, shows that the increase in the rate of influenza consultations has stall ..

CEL-SCI Corporation (NYSE Amex: CVM), a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today that an Instit ..

Novartis announced that it received approval from the German regulatory authorities for its adjuvanted cell culture-based Influenza A(H1N1) 2009 monovalent vaccine, Celtura®. Novartis continues to pu ..

The U.S. Department of Health and Human Services (HHS) announced contract awards for up to 120,000 treatment courses of intravenous (IV) antiviral drugs to help treat hospitalized 2009 H1N1 influenza ..

An editorial published today in BMJ Clinical Evidence reports that more flu viruses could qualify as pandemic strains as a result of recent changes to the World Health Organisation (WHO) criteria for ..

Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Inst ..